Definium Therapeutics (DFTX) Shareholder's Equity Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.15% |
| Dec 31, 2025 | 37.64% |
| Sep 30, 2025 | -50.19% |
| Jun 30, 2025 | -8.24% |
| Mar 31, 2025 | 13.64% |
| Dec 31, 2024 | 209.02% |
| Sep 30, 2024 | 173.18% |
| Jun 30, 2024 | 90.66% |
| Mar 31, 2024 | 50.42% |
| Dec 31, 2023 | -48.23% |
| Sep 30, 2023 | -37.51% |
| Jun 30, 2023 | -14.88% |
| Mar 31, 2023 | -4.72% |
| Dec 31, 2022 | -0.49% |
| Sep 30, 2022 | -6.50% |
| Jun 30, 2022 | -27.46% |
| Mar 31, 2022 | -24.25% |
| Dec 31, 2021 | 99.91% |
| Mar 31, 2021 | -3.73% |
| Dec 31, 2020 | 1,488.53% |